BSE filing, NSE: TATAELXSI. Summary written from the filing by ALFA Finder's alert engine.
Tata Elxsi Ltd: key numbers
- Share price
- ₹3,755.00
- Market cap
- ₹23,396 Cr
- Revenue (annual)
- ₹3,757 Cr
- Net profit (annual)
- ₹628.4 Cr
- P/E (TTM)
- 34.9×Sector 22.9×
- Promoter holding
- 43.89%-0.01% QoQ
- FII holding
- 8.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Tata Elxsi Ltd
All →Tata Elxsi Other Announcement
Tata Elxsi filed its quarterly shareholding pattern as of 30 June 2025. This routine periodic disclosure reports holdings only, with no transaction or corporate event.
Tata Elxsi Other Announcement
Tata Elxsi Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulatory requirements.
Tata Elxsi Earnings Call Transcript: Key Takeaways
Tata Elxsi reported steady constant currency revenue growth and margin expansion despite wage hikes.
Tata Elxsi Management Change
Tata Elxsi Limited has appointed Deloitte Haskins & Sells Chartered Accountants LLP as the new statutory auditor for a 60-month term effective from April 1, 2027.
Tata Elxsi Employee Stock Options
Tata Elxsi Limited allotted 686 equity shares to employees upon the exercise of performance stock options. This allotment increases the company's paid-up equity share capital.
Tata Elxsi Investor Presentation: Key Takeaways
Tata Elxsi reported Q2 FY27 revenue of Rs. 1,055.7 Cr, up 3.4% QoQ. Strategy focuses on broad-based growth across Transportation, Media, and Healthcare using GenAI.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date